Prevalence of Hepatitis C and Related Factors among Beta-Thalassemia Major Patients in Southern Iran in 2005-2006

[1]  I. Mohammadzadeh,et al.  Seroprevalence of HCV antibody among patients with beta-thalassemia major in Amirkola Thalassemia Center, Iran. , 2007, Iranian Journal of Allergy, Asthma and Immunology.

[2]  E. Hajiani,et al.  Hepatis C virus transmission and its risk factors within families of patients infected with hepatitis C virus in southern Iran: Khuzestan. , 2006, World journal of gastroenterology.

[3]  S. Alavian,et al.  Epidemiology of hepatitis B, hepatitis C, and human immunodeficiency virus infecions in patients with beta-thalassemia in Iran: a multicenter study. , 2006, Archives of Iranian medicine.

[4]  T. Tsukatani,et al.  Evaluation of the national health policy of thalassaemia screening in the Islamic Republic of Iran. , 2005, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit.

[5]  E. Neufeld,et al.  Complications of beta-thalassemia major in North America. , 2004, Blood.

[6]  M. Shahriari,et al.  Prevalence of endocrine complications in beta-thalassaemia major in the Islamic Republic of Iran. , 2003, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit.

[7]  H. Yarmohammadi,et al.  β-THALASSEMIA INTERMEDIA FROM SOUTHERN IRAN: IVS-II-1 (G→A) IS THE PREVALENT THALASSEMIA INTERMEDIA ALLELE , 2002, Hemoglobin.

[8]  D. Lavanchy,et al.  High prevalence of hepatitis C virus among urban and rural population groups in Egypt. , 1995, Acta tropica.